JG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Moderna, Inc. (MRNA) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Moderna, Inc. (MRNA) stock worth $1K-$15K in a STOCK Act filing on Apr 20, 2023.
The trade happened on Mar 31, 2023, 20 days before it was made public.
MRNA has moved +23.7% since the trade date, from $153.58 to $190.01 (Oct 2, 2026 close).
- Traded
- Mar 31, 2023
- Disclosed
- Apr 20, 2023
- Filing delay
- 20 days
- Price since
- +23.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (44)
- SellFIS$15K-$50KApr 20, 2023
- SellAAPL$1K-$15KApr 20, 2023
- BuyABBV$1K-$15KApr 20, 2023
- SellABBV$1K-$15KApr 20, 2023
- SellABCB$1K-$15KApr 20, 2023
- BuyALGN$1K-$15KApr 20, 2023
- SellAMGN$1K-$15KApr 20, 2023
- SellAMGN$1K-$15KApr 20, 2023
- BuyAPPF$1K-$15KApr 20, 2023
- BuyASML$1K-$15KApr 20, 2023
- SellCCI$1K-$15KApr 20, 2023
- SellCOP$1K-$15KApr 20, 2023
- SellCOP$1K-$15KApr 20, 2023
- SellDE$1K-$15KApr 20, 2023
- SellGOOG$1K-$15KApr 20, 2023
- SellGOOG$1K-$15KApr 20, 2023
- SellGOOG$1K-$15KApr 20, 2023
- BuyHLN$1K-$15KApr 20, 2023
- SellKO$1K-$15KApr 20, 2023
- SellLLY$1K-$15KApr 20, 2023
More MRNA insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.